A detailed history of Hilton Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Hilton Capital Management, LLC holds 59,051 shares of NVO stock, worth $8.43 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
59,051
Previous 59,171 0.2%
Holding current value
$8.43 Million
Previous $6.12 Million 23.87%
% of portfolio
0.69%
Previous 0.67%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $12,253 - $16,310
-120 Reduced 0.2%
59,051 $7.58 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $1,053 - $1,265
12 Added 0.02%
59,171 $6.12 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $2.6 Million - $5.7 Million
28,571 Added 93.41%
59,159 $5.38 Million
Q2 2023

Jul 31, 2023

BUY
$155.98 - $172.65 $4.77 Million - $5.28 Million
30,588 New
30,588 $4.95 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hilton Capital Management, LLC Portfolio

Follow Hilton Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilton Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hilton Capital Management, LLC with notifications on news.